Provided by Tiger Trade Technology Pte. Ltd.

Olema Pharmaceuticals, Inc.

10.69
-0.2100-1.93%
Post-market: 10.690.00000.00%19:43 EDT
Volume:748.54K
Turnover:8.13M
Market Cap:931.71M
PE:-5.02
High:11.24
Open:10.90
Low:10.65
Close:10.90
52wk High:36.26
52wk Low:5.36
Shares:87.16M
Float Shares:71.89M
Volume Ratio:0.64
T/O Rate:1.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1289
EPS(LYR):-1.8700
ROE:-52.74%
ROA:-31.82%
PB:2.16
PE(LYR):-5.72

Loading ...

Jul 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 27, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 21, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 11, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Major Issues Report

8-K - Current report